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PLACE-CONDITIONING PROCEDURES ARE BASED on the establishment of a Pavlovian relationship between 
distinctive environmental cues and some effects of a drug 
(Carr et al., 1989). Subsequent approach or withdrawal behav-
iors to drug-paired cues are thought to index drug motivational 
properties. A number of place-conditioning designs have estab-
lished that many abused or self-administered (i.e., reinforcing) 
drugs will produce a conditioned place preference (CPP) (Carr 
et al., 1989; Hoffman, 1989; Tzschentke, 1998). This gener-
al paradigm has successfully been used to examine environ-
mental, genetic, and neurochemical determinants of drug re-
ward [including ethanol (EtOH)]. This symposium examined 
recent advances in our knowledge of EtOH reward on the ba-
sis of studies using the place-conditioning procedure. Dr. Rick 
Bevins reviewed methodological, empirical, and theoretical is-
sues related to the use of this technique to study non-EtOH re-
inforcers. Dr. Frank Holloway described the role of historical 
factors in the development of EtOH-induced conditioned place 
aversion (CPA) and CPP in rats. Dr. Christopher Cunningham 
reviewed recent studies of genetic and environmental infl uenc-
es on EtOH place conditioning in mice. Finally, Dr. Fred Ris-
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inger addressed contributions of this procedure to our under-
standing of the neurobiology of EtOH reward. 
PLACE CONDITIONING: UNDERSTANDING THE
MOTIVATIONAL IMPACT OF STIMULI
Rick A. Bevins 
Stimuli in the environment can affect an animal such that it 
is more likely to engage in approach or avoidance behaviors. 
Place conditioning has become a popular experimental prepa-
ration for studying these motivational shifts—especially those 
shifts produced by drugs of abuse (for reviews, see Bardo and 
Bevins, 2000; Carr et al., 1989, Tzschentke, 1998). The early 
popularity of place conditioning has been attributed to the rel-
ative ease with which place conditioning is established in the 
laboratory. This argument is partially true when the comparison 
preparation is drug self-administration. For instance, the pur-
chasing/building cost of the apparatus is cheaper, the animals 
can receive drugs systemically (surgery is not necessary), and 
the duration required to establish place conditioning is short-
er. This methodological comparison, however, should be taken 
with caution. For instance, early methodological comparisons 
between place conditioning and self-administration assumed 
that the preparations were measuring common processes. The 
data no longer support this notion (see below). Furthermore, 
this methodological comparison obscures the fact that there is 
much labor involved in establishing a standardized protocol in 
the laboratory. For example, given that a drug is differential-
ly paired with one of two distinct environments, the apparatus 
has to be built, tested, modifi ed, retested, and so on to ensure 
that there is no strong unconditioned preference for either en-
vironment under initial and extended exposure. Even in a well 
balanced apparatus, rats will display an unconditioned prefer-
ence for an environment. Thus, a further methodological con-
sideration includes whether to ignore these individual differ-
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ences and pair the drug with a randomly selected environment 
(unbiased design; see following paragraph) or to pair the drug 
with, say, the nonpreferred compartment (see below). 
Using an unbiased design, we sought to fi nd the effective 
dose range for intravenous (iv) cocaine. Male Sprague-Daw-
ley rats were surgically prepared with a catheter into the left 
external jugular vein. After a recovery period, rats were con-
fi ned for 10 min to the place-conditioning chamber twice a 
day on four consecutive days (each confi nement separated by 
6 hr). One daily confi nement was in a white end compartment 
that had a mesh fl oor; the other confi nement was in a black 
end compartment that had a rod fl oor. Rats received an iv in-
fusion of cocaine (0.1, 0.3, 0.45, 0.6, 0.9, or 1.2 mg/kg) in one 
end compartment (randomly selected) and saline in the oth-
er end compartment (i.e., unbiased procedure). Controls re-
ceived an infusion of saline immediately upon placement in 
both end compartments. The day after the last confi nement was 
a drug-free test for conditioning. Rats were placed in a center 
gray compartment and allowed free access to both end com-
partments for 10 min. Controls and rats treated with 0.1 and 
0.3 mg/kg of cocaine spent comparable time in both end com-
partments. In contrast, rats treated with 0.45 mg/kg of cocaine 
or more spent more time in the cocaine-paired environment 
(i.e., a cocaine CPP). This increase in time likely refl ects rats’ 
predisposed tendency to approach appetitive/rewarding stim-
uli. That is, the environment presumably acquires secondary 
rewarding value by virtue of being reliably paired with the re-
warding effects of cocaine. Thus, the secondary rewarding ef-
fects of the environment evoke approach behavior, resulting in 
an increase in time spent in the paired environment (cf Ikemo-
to and Panksepp, 1999). 
Although the bulk of place-conditioning research has ex-
amined abused drugs, the rewarding effects of such stimuli as 
food, water, wheel running, and copulatory opportunity have 
also received empirical attention. A recent example from our 
laboratory is the rewarding effects of novel stimulation. From 
a drug-abuse perspective, novelty reward is of interest given 
the positive correlation between novelty/ sensation seeking 
and drug use in humans (Zuckerman, 1994). An underlying as-
sumption is that this higher drug use and abuse rate in novel-
ty seekers refl ects common neurobiological processes between 
novelty and drugs (Bardo et al., 1996). After initial pretests 
for compartment preference, rats received repeated access to a 
novel object while they were confi ned to the nonpreferred com-
partment (i.e., the end compartment in which the least amount 
of time was spent during the pretest). They received equal ex-
posure to the preferred compartment without objects (i.e., bi-
ased design). In a subsequent choice test, rats increased their 
preference for the novelty-paired compartment according to 
within-subject and between-subject measures (Bevins and Bar-
do, 1999). If the object is familiar, then no systematic shift in 
preference occurs (Bevins et al., 2002). Subsequent work has 
shown that dopaminergic processes mediating expression of 
novelty reward are similar to those of cocaine (Besheer et al., 
1999; Cervo and Samanin, 1995). Further, in a one-trial place-
conditioning procedure, a dose of iv cocaine that does not pro-
duce a preference alone will condition a place preference when 
access to a novel object co-occurs with the administration of 
cocaine. Importantly, access to a novel object alone in this one-
trial procedure is also insuffi cient to condition a place prefer-
ence. This data pattern was taken to indicate that the rewarding 
effects of cocaine summate with novelty (Bevins, 2001). 
The summation experiment between cocaine and novel-
ty used a single conditioning trial. This sensitivity to a sin-
gle stimulus exposure is an important, but underused, feature 
of the place-conditioning preparation. In addition to allowing 
researchers to assess the motivational effect of acute drug ad-
ministration, this feature seems well suited for developmen-
tal and other time-sensitive research (e.g., drug withdrawal). 
Furthermore, humans readily display learning in a single tri-
al; the ability of place-conditioning procedures to index learn-
ing after a single trial may provide some construct validity to 
this animal model. Related to the latter point is the clinical ob-
servation that retrospective reports on positive fi rst drug expe-
riences may predict vulnerability for drug abuse (Haertzen et 
al., 1983). We attempted a laboratory analog of this observa-
tion. Briefl y, we fi rst assessed the acute rewarding effect of iv 
amphetamine (1 mg/kg) in a place-conditioning situation with 
rats (i.e., fi rst drug experience). These rats were then allowed 
to self-administer 30 μg per infusion of amphetamine (i.e., 
chronic reinforcing effects). The shift in place preference con-
ditioned by a single amphetamine infusion was not signifi cant-
ly correlated with subsequent self-administration (Bardo et al., 
1999). This result, combined with other research (see Bardo 
and Bevins, 2000), emphasizes the importance of understand-
ing the processes underlying the ability of abused drugs to pro-
duce conditioned shifts in preference (i.e., place conditioning), 
as well as understanding their ability to maintain drug-taking 
behavior (i.e., self-administration). That is, the place-condi-
tioning preparation likely measures drug processes involved in 
the etiology of drug abuse distinct from self-administration. 
Role of Historical Factors in Ethanol Place Conditioning 
Frank A. Holloway Tolerance to EtOH develops when re-
peated exposure to a given dose results in a decreased effect 
for that dose and an increase in the dose required to reproduce 
the initial EtOH dose effect. Although EtOH tolerance and de-
pendence may develop independently, a possible relationship 
may exist between tolerance and the subsequent increase in 
EtOH consumption, which could eventually produce physi-
cal dependence. For example, tolerance development to the re-
ward properties of EtOH might set the occasion for increased 
EtOH intake. However, studies examining shifts in the magni-
tude of EtOH reward after extended EtOH exposure have re-
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ported mixed results (Carney et al., 1976; Karoly et al., 1978). 
An alternative hypothesis is that increased EtOH consumption 
is permitted or facilitated by tolerance development to some of 
EtOH’s disruptive or dysphoric effects (Holloway et al., 1988). 
According to this account, tolerance contributes to or facilitates 
EtOH consumption by reducing the costs of drinking, there-
by enhancing the relative reward value of EtOH. Clearly, the 
latter hypothesis requires research addressing the role of both 
behavioral and physiologic factors in the development of tol-
erance to EtOH’s behaviorally disruptive effects and also the 
relationship between such tolerance development and EtOH’s 
reward effects. The latter can be assessed with the EtOH place-
conditioning assay, which provides an index of approach to or 
avoidance of EtOH-paired contexts. 
In studies using a rat operant model, we have reported that 
the behavioral tolerance that developed to the rate-decreas-
ing (and rate-increasing) effects of EtOH (a) lasted for up to 6 
months (Bird et al., 1985; Bird and Holloway, 1989; Holloway 
et al., 1988); (b) was jointly dependent on intoxicated practice 
and on some threshold exposure to EtOH; (c) was paralleled 
by the emergence of baseline response rate increases (Bird and 
Holloway, 1989; Holloway and King, 1989); (d) was not pres-
ent in chronic EtOH controls with no EtOH-related task ex-
perience (Holloway et al., 1989); (e) was not due to metabol-
ic or distributional factors and was not dependent on the mode 
or context of EtOH administration; (Holloway et al., 1992a); 
and (f) was produced by postsession EtOH exposure (see be-
low) that led to rate decreases up to 24 hr later (Holloway and 
King, 1989; Holloway et al., 1992b, 1993). We hypothesize 
that (a) the effective condition for EtOH tolerance develop-
ment in the operant task is an interaction between the EtOH 
dose and the functional demand placed on the organism; (b) if 
this interaction leads to an unfavorable consequence, e.g., loss 
of reinforcements, then the animal will be motivated to learn 
any compensatory behavior that counteracts EtOH’s effects; 
(c) positive cross-tolerance effects will be found for any sit-
uations producing similar behavioral demands, and negative-
cross tolerance effects will be found for situations producing 
opposite behavioral demands; and (d) the last tolerance devel-
opment sets the occasion for a positive hedonic shift in EtOH’s 
motivational effects. 
We and others (Gauvin et al., 1989, 1992, 1993a,b; Hollo-
way et al., 1993) have also demonstrated that an EtOH induced 
homeostatic compensatory or “hangover” effect occurs approx-
imately 12 to 24 hr after an acute high-dose injection of EtOH. 
Also, we demonstrated that rats receiving chronic EtOH injec-
tions 20 to 22 hr before a fi xed-ratio (FR) operant task demon-
strated an initial rate suppression (Holloway and King, 1989). 
The rats subsequently became tolerant to this EtOH delayed 
effect (EDE) and displayed cross-generalization of EDE toler-
ance to the immediate effects of presession EtOH. These data 
suggested a complex interaction among behavioral, temporal, 
and conditioning factors operative during the development of 
EtOH tolerance. We hypothesized that this tolerance derives 
largely from the learning of a compensatory behavioral adjust-
ment to either the immediate or delayed effects of EtOH on be-
havior. It is unclear how the delayed effects of EtOH contribute 
to the development of tolerance to EtOH’s direct intoxicating 
effects or whether it is specifi c to the rate-reducing effects of 
EtOH. It would be of interest to assess the relative contribu-
tion of the delayed effect phenomenon to the development of 
the rate-increasing and rate-decreasing effects of EtOH. This 
delayed effect of acute EtOH treatment may be the result of 
homeostatic compensatory responses that oppose its direct in-
toxicating effects. However, the behavioral effects (i.e., rate re-
duction in an FR task) seem to be in the same direction as the 
intoxicating effects. In subsequent experiments, we demon-
strated that at least part of the EDE is due to a general disrup-
tion of circadian rhythms, not dissimilar to jet lag (Gauvin et 
al., 1997a), with the potential for infl uencing EtOH consump-
tion (Gauvin et al., 1997b) and physiology (Baird et al., 1998). 
In some studies, tolerance may be mediated by behavioral 
adjustments that allow rewarding stimuli to be acquired. Taba-
koff and Hoffman (1988) have suggested that repeated admin-
istration of EtOH may produce tolerance to certain aversive 
properties that would allow an individual to be more able to 
consume larger quantities of EtOH. Earlier studies in our labo-
ratory have shown that the acquisition of the kind of behavioral 
tolerance described previously will produce EtOH CPP (Hollo-
way et al., 1992a) and will block the acquisition of conditioned 
taste aversion (Gauvin and Holloway, 1992a), rather than the 
conditioned place and taste aversions seen in rats without such 
a history. Other behavioral histories also alter EtOH’s hedon-
ic effects. For example, prior acquisition of oral EtOH self-ad-
ministration produces subsequent EtOH place preference, and 
prior establishment of an EtOH discriminative cue blocks the 
normally seen EtOH place aversion (Gauvin and Holloway, 
1992b). 
This paper extends our analysis of EtOH tolerance in a rat 
operant model to focus on the following questions. (a) What 
are the relative and interactive roles played by the EDE or 
EtOH’s immediate effects on the development of behavioral 
tolerance with an FR operant task? (b) What are the relative 
contributions of tolerance development to the immediate, de-
layed, or immediate and delayed EtOH effects on subsequent 
changes in EtOH’s positive or negative hedonic properties? (c) 
Specifi cally, are EtOH’s rewarding or aversive properties (as 
measured by EtOH place learning) modulated by prior toler-
ance development to any of these effects of EtOH? 
Phase I studies were designed to differentiate the contribu-
tions of the direct intoxicating effects and the delayed effects 
of EtOH on the development of tolerance to EtOH’s direct ef-
fects on operant performance in rats. Using a (3 x 6) group x 
treatment design, we determined behavioral dose-effect curves 
(DECs) for EtOH’s direct intoxicating effects on performance 
of an FR-30 operant task, by using both cumulative and sin-
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gle-session procedures: (a) before a 30-day period of daily in-
jections (DEC 1); (b) at the end of the period of daily injec-
tions (DEC-2); and (c) 1 month later (DEC-3). Phase I studies 
required fi ve groups of rats (n = 8 per group): EI, EtOH’s im-
mediate effects only; ED, EtOH’s delayed effects only; EID, 
EtOH’s immediate and delayed effects; SC, saline control (no 
EtOH in phase I); and EC, EtOH control (no phase I practice 
during either ETOH’s immediate or delayed effects. 
Once stable performance was achieved in each group on 
their respective schedules and DEC-1 tests were completed, 
daily phase I EtOH injections commenced. The chronic dosing 
regimen comprised incremental injections over 4 weeks from 
initial doses of 1.25 g/kg up to 2.0 g/kg. Only groups EI, ED, 
and EID and the EC groups received EtOH injections. The SC 
group received volume-equivalent injections of normal saline. 
In the cumulative dosing animals, a signifi cant shift to the 
right in the DECs for ETOH’s rate-decreasing effects were ev-
ident in the EID, EI, and ED groups, but not in the SC and EC 
groups. In the animals whose DECs were determined by sepa-
rate single session tests, similar results were obtained, but with 
the EID group showing the greatest amount of tolerance. 
Phase II studies assessed the effects of antecedent tolerance 
development on the relative hedonic valences of EtOH in the 
phase I groups by using the EtOH place-conditioning para-
digm. If the hedonically positive properties of EtOH are some-
how unmasked by or dependent on the development of behav-
ioral tolerance, then the prior exposure from phase I should be 
sensitive enough to elicit the acquisition of a CPA or prefer-
ence in phase II. The procedure involved pairing EtOH or ve-
hicle in one of two distinctive side chambers during training 
sessions (two of each per week) followed by a no-injection test 
session with access to the center start compartment and the two 
side compartments. All sessions were 30 min long. Four EtOH- 
and four water-conditioning sessions were conducted between 
each test. 
We anticipated a signifi cant place learning resulting from 
the prior drug and experiment history in this experiment. The 
development of behavioral tolerance under the schedule-con-
trolled operant tasks in the proposed study may be associated 
with the concurrent development of tolerance to EtOH’s aver-
sive properties. In the cumulative-dosing study, the rank order 
for time spent on the EtOH-paired side of the chambers was 
group EID > group EI > group ED > group EC > group SC. 
In the rats tested with single-session tests, only the EID group 
showed marked EtOH place preference, with the EI and ED 
groups showing neither place preference nor place aversion 
and the SC group showing clear place aversion. 
In summary, these sets of data indicate that (a) in EtOH-
naive rats, EtOH produces both CPA and conditioned taste 
aversion; (b) the prior acquisition of tolerance to EtOH’s de-
creasing effects on FR-30 operant performance blocks EtOH-
induced conditioned taste aversion and, independent of con-
text, produces EtOH-induced CPP; and (c) furthermore, the 
prior establishment of EtOH drug discrimination or self-ad-
ministration, respectively, blocks EtOH-induced conditioned 
taste aversion and produces EtOH-induced CPP. From these 
studies, a fi nal caveat is that prior EtOH exposure alone prob-
ably mitigates some of the negative hedonic effects of EtOH 
seen in EtOH place conditioning. Future studies must look at 
both prior EtOH/ behavior histories and at place conditioning 
under both EtOH’s immediate and delayed effects. This is par-
ticularly true because we have reported a paradoxical place 
preference for EtOH’s delayed, or hangover, effects (Gauvin 
et al., 1997c). 
Ethanol Place Conditioning in Mice: Genetic and Environ-
mental Infl uences 
Christopher L. Cunningham Although it has been rather dif-
fi cult to demonstrate EtOH-induced CPP in drug-naive rats, the 
literature now offers substantial evidence of such condition-
ing in mice. In the most commonly reported procedure, mice 
are exposed to a discriminative Pavlovian conditioning proce-
dure in which distinctive tactile stimuli provided by the fl oor 
of the apparatus are paired with intraperitoneal injection of ei-
ther EtOH [conditioned stimulus (CS) + trials] or saline (CS - 
trials). After four or more pairings of each type, mice are given 
a choice test in which access to both sets of stimuli is allowed 
in the absence of EtOH. The general result of such tests is that 
mice spend more time on a target fl oor when it has previous-
ly been paired with EtOH than when it has not (e.g., Cunning-
ham et al., 1992). 
The strength of EtOH-induced CPP is known to be infl u-
enced by many variables. For example, CPP is positively re-
lated to EtOH dose (Risinger et al., 1994), even up to dose lev-
els that result in loss of the righting refl ex (Cunningham et al., 
1992; Risinger and Oakes, 1996a). The initial observation of 
CPP at doses that produced loss of righting suggested that the 
critical time period for producing this learning was during the 
fi rst few minutes after injection, when blood EtOH levels were 
increasing. A study of conditioning trial duration supported 
this suggestion, showing that EtOH-induced CPP was stronger 
with short (5-min) trial durations than with long (30-min) tri-
al durations (Cunningham and Prather, 1992). The Pavlovian 
nature of EtOH-induced CPP is further supported by the ob-
servation that repeated postconditioning exposure to the CS + 
without EtOH results in extinction of CPP (Cunningham and 
Henderson, 2000). 
Many studies have examined genetic infl uences on EtOH-
induced CPP. For example, studies conducted with selective-
ly bred mice have shown that sensitivity to EtOH-induced CPP 
is genetically correlated with sensitivity to EtOH’s thermal ef-
fect (Cunningham et al., 1991) and EtOH withdrawal (Ches-
ter et al., 1998; Crabbe et al., 1992). There are also substantial 
differences in place conditioning across standard inbred strains 
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(Cunningham et al., 1996) and recombinant inbred strains 
(Cunningham, 1995). Moreover, recent studies have shown 
that this procedure is able to detect differences produced by 
targeted gene mutation (e.g., Cunningham et al., 2000; Rising-
er et al., 1996, 2001). Of the more than six dozen genotypes 
that have been examined over the last 12 years, nearly 75% 
have been found to show CPP with EtOH. Thus far, we have 
not found any strain that shows CPA with EtOH with our stan-
dard training procedures. 
A recent project has further confi rmed the infl uence of gen-
otype by the successful selective breeding of mice for differ-
ences in sensitivity to EtOH-induced CPP (Hill and Cunning-
ham, 2001). B6D2F2 mice served as the parent population, 
and a mass selection strategy was used, although brother-sis-
ter matings were avoided. The mean percentage of time spent 
on the EtOH-paired fl oor was used as the phenotype, and bidi-
rectional selection was continued for fi ve generations. A signif-
icant difference between the high–place preference and low–
place preference lines emerged in the third generation and was 
maintained over the next two generations. Interestingly, a line 
difference in EtOH-stimulated activity emerged as a correlated 
response to selection (i.e., high–place preference mice showed 
greater EtOH-induced activity than low–place preference 
mice), although there was no line difference in basal activi-
ty. This fi nding raises the possibility of overlap in the genetic 
mechanisms that infl uence EtOH CPP and locomotor activa-
tion. However, it is not consistent with previous studies sug-
gesting dissociation in the mechanisms underlying these traits 
(e.g., Risinger et al., 1994). 
The time interval between EtOH injection and exposure to 
the CS has been found to have a profound infl uence on EtOH-
induced place conditioning in mice. More specifi cally, injec-
tion of EtOH immediately or 30 min before the CS has consis-
tently been found to produce CPP, whereas injection of EtOH 
immediately after (but not 15 or 60 min after) the CS has been 
found to produce CPA (Cunningham et al., 1997). Additional 
studies have shown that CPA produced by post-CS EtOH expo-
sure is positively related to EtOH dose, inversely related to tri-
al duration, reduced by CS-only extinction trials, and reduced 
by prior EtOH exposure (Cunningham and Henderson, 2000). 
The strength of EtOH-induced CPA also varies as a function 
of genotype (Cunningham and Ignatoff, 2000). The fi nding of 
aversion with post-CS drug exposure is not unique to EtOH. 
We recently reported that CPA is also produced by post-CS 
injection of many different abused drugs, including nicotine, 
morphine, cocaine, amphetamine, and diazepam (Cunningham 
et al., 2001). 
Genetic correlational analyses show no signifi cant relation-
ship between EtOH-induced CPP and EtOH-induced CPA, 
suggesting that these phenomena represent relatively indepen-
dent effects of EtOH. However, EtOH-induced CPA is geneti-
cally correlated with EtOH-induced conditioned taste aversion 
and EtOH consumption, suggesting overlap in the genes infl u-
encing these phenotypes. We currently hypothesize that EtOH-
induced CPA is caused by the novelty of the rapid transition 
in drug state that occurs when EtOH and other abused drugs 
are injected. Pre-exposure to EtOH presumably reduces CPA 
by reducing the novelty of that rapid change in state (Cunning-
ham et al., 2002). 
In summary, a substantial body of literature shows that place 
conditioning provides a reliable measure of EtOH’s rewarding 
effects in mice. EtOH-induced CPP is sensitive to genotype 
and several variables thought to infl uence Pavlovian condition-
ing. Thus, as will be illustrated in the next section, the model 
is well suited for studying the neurobiological mechanisms un-
derlying EtOH’s rewarding and aversive effects. 
Utilization of Place Conditioning for Understanding the Neu-
ropharmacology of the Rewarding Effects of Ethanol 
Fred O. Risinger Several theories of drug abuse or addic-
tion have attributed drug reward or reinforcement to specifi c 
neurotransmitter systems and neuroanatomical pathways (e.g., 
Koob, 1992; Samson and Harris, 1992; Wise, 1998). Drug re-
ward, as well as the action of other rewarding stimuli (e.g., 
food), has often been attributed to activity in the mesolimbic 
dopamine system (Wise, 1996; Wise and Rompre, 1989). For 
example, dopamine D2 receptor function has been suggested 
as playing a general role in reward (Wise et al., 1978). How-
ever, more recently, dopaminergic systems have been suggest-
ed to mediate the production of instrumental responding rather 
than mediation of reward per se (Salamone et al., 1997). Al-
though substantial data support the importance of dopaminer-
gic systems in the rewarding effects of amphetamine and co-
caine (Hoffman, 1989; LeMoal and Simon, 1991), it is less 
clear that other drugs of abuse operate in a similar manner 
(Koob, 1992). For example, although mice lacking dopamine 
D2 receptors drink less EtOH, this effect has been proposed to 
be due to a nonspecifi c reduction in response output (Rising-
er et al., 2000, 2001). Koob (1992) has proposed drug reward 
models emphasizing the importance of the nucleus accumbens 
and has further proposed an important role for y-aminobutyr-
ic acid (GABA)-A receptors in the acute reinforcing effects of 
sedative hypnotics and EtOH. Opioid and noradrenergic sys-
tems have also been suggested to be important for EtOH’s re-
warding or aversive effects (e.g., Amit and Brown, 1982; Mc-
Bride et al., 1999; Weiss and Koob, 1991). Furthermore, a large 
body of literature has suggested that serotonin systems are im-
portant in EtOH preference (McBride and Li, 1998). For ex-
ample, serotonergic systems in the dorsal raphe nucleus, with 
projections to the nucleus accumbens, have been proposed as 
one potential site of action mediating EtOH reward (McBride 
et al., 1989, 1990). 
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Although it is clear that a number of neurotransmitter sys-
tems are importantly involved with EtOH reinforcement, no 
exclusive role for a specifi c neurotransmitter system has been 
established for EtOH’s direct motivational effects. Several 
studies indicate the involvement of serotonin systems in EtOH 
preference (Maurel et al., 2000; McBride et al., 1989, 1995). 
Dopaminergic receptor systems also seem to have prominent 
importance for drug reinforcement (McBride et al., 1999; Wise, 
1998), as well as GABA receptor systems and opioid receptor 
systems (Koob, 2000). Dopaminergic, GABAergic, serotoner-
gic, and opioid drugs reduce operant responding for EtOH re-
inforcement or EtOH intake (Haraguchi et al., 1990; June et 
al., 1999; Middaugh and Bandy, 2000; Pfeffer and Samson, 
1988). 
The studies described herein have explored the role of sev-
eral neurotransmitter systems in EtOH reward. As indicated 
in the previous section, several strains of mice readily acquire 
conditioned preference to fl oor cues paired with systemic ex-
posure to EtOH. Many of our studies have used the relative-
ly inexpensive Swiss-Webster mouse strain. Swiss-Webster 
mice acquire EtOH-induced CPP, although less readily than 
more sensitive strains such as DBA/2J (Risinger and Oakes, 
1996a). In these studies, treatment with drugs having at least 
some neurotransmitter-specifi c actions occurs just before ex-
posure to EtOH and the conditioning fl oor cues. Subsequent-
ly, preference testing determines the actions of these selected 
drugs on the acquisition of this response. In some cases, mu-
tant mice lacking a neurotransmitter function of interest were 
also tested. Our procedure typically involves four to six con-
ditioning trials, with preference testing after at least four trials. 
The apparatus allows for the assessment of locomotor activity, 
which, during conditioning, enables the determination of the 
infl uence of drugs on EtOH-stimulated activity. Our designs 
also include treatment with the drug in the absence of EtOH 
to determine the motivational effects of the drug per se. Thus, 
drug-treatment comparisons are based on data from groups re-
ceiving EtOH, drug treatment plus EtOH, and drug treatment 
alone. Genotype comparisons in studies with mutant mice are 
based on groups of knock-out and wild-type mice receiving 
EtOH. 
Several studies were devoted to the examination of sero-
tonin systems. In general, a large body of data mentioned pre-
viously has indicated that serotonin systems are important for 
EtOH intake. However, changes in intake may refl ect sever-
al processes. Decreased intake may refl ect decreased experi-
ence of reward, increased experience of aversion, nonspecifi c 
anorexia, or nonspecifi c motor effects. For example, the se-
rotonin uptake inhibitor fl uoxetine, as well as other serotonin 
uptake inhibitors, reduce EtOH consumption (Gill and Amit, 
1989). However, fl uoxetine did not alter the acquisition of 
EtOH-induced CPP (Risinger, 1997). Fluoxetine did enhance 
the acquisition of EtOH-induced conditioned taste aversion 
and enhanced the discriminative stimulus properties of EtOH 
(Risinger, 1997). More receptor-specifi c serotonergic agents 
have also been tested. Mianserin, a 5-hydroxytryptamine-2 (5-
HT2) receptor antagonist, was found to enhance the magnitude 
of EtOH-induced CPP. This effect was not coupled with any 
nonspecifi c motivational actions, because groups of mice treat-
ed with mianserin alone did not show evidence of condition-
ing (Risinger and Oakes, 1996b). However, mianserin reduced 
locomotor activity during the conditioning trials, indicating 
that the dose used (10 mg/kg) was behaviorally active. Simi-
lar results have been seen with pindobind-5HT1A, a 5-HT1A 
antagonist, which also enhanced the acquisition of EtOH-in-
duced CPP but did not infl uence EtOH-induced conditioned 
taste aversion, EtOH-stimulated activity, or EtOH behavioral 
sensitization (Risinger and Boyce, 2002). Interest in the role 
of 5-HT1B receptors for determining sensitivity to EtOH was 
encouraged by the report that 5-HT1B knock-out mice drink 
large quantities of EtOH (Crabbe et al., 1996). However, more 
recent articles suggest that this effect is modest at best (Bouwk-
nect et al., 2000; Crabbe et al., 1999; Risinger et al., 1999b). 5-
HT1B knock-out mice were not able to acquire signifi cant CPP 
to EtOH but readily demonstrated the acquisition of EtOH-in-
duced conditioned taste aversion (Risinger et al., 1996). 
Studies aimed at describing the role of dopamine receptor 
systems have also used both pharmacological manipulations 
and genotype comparisons. Dopamine systems feature prom-
inently in drug-reward models (e.g., Koob et al., 1998). An 
early study revealed that haloperidol reduced EtOH-stimulat-
ed activity during conditioning but did not alter the acquisition 
of EtOH-induced CPP (Risinger et al., 1992a). Clozapine also 
did not change the acquisition of EtOH-induced CPP but re-
duced EtOH-stimulated activity (Thrasher et al., 1999). How-
ever, both haloperidol and clozapine reduced the acquisition 
of EtOH-induced conditioned taste aversion (Risinger et al., 
1999a; Thrasher et al., 1999). In contrast, U99194A, a dopa-
mine D3 antagonist, enhanced the acquisition of EtOH-induced 
CPP (Boyce and Risinger, 2000, 2002). These results togeth-
er suggest limited involvement of dopamine D2 and D4 recep-
tors in EtOH reward but a possible role for dopamine D3 re-
ceptors. However, studies with selected mutants do not provide 
data that completely overlap with outcomes based on pharma-
cological manipulations. For example, dopamine D2 receptor 
knock-out mice did not acquire EtOH-induced CPP (Cunning-
ham et al., 2000). Similarly, mice lacking the intracellular sig-
naling protein DARPP-32 did not acquire this response (Ris-
inger et al., 2001). 
Although serotonin and dopamine systems often feature 
prominently in drug-reward models, other neurochemical 
mechanisms seem important for EtOH reward. Several stud-
ies have explored the role of GABA-related systems. These 
include an early study using the benzodiazepine receptor in-
verse agonist RO 15-1788, which did not alter the acquisition 
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of EtOH CPP (Risinger et al., 1992b). More recently, applica-
tion of the GABAA antagonists bicuculline or picrotoxin en-
hanced the acquisition of EtOH CPP (Chester and Cunning-
ham, 1999a), whereas the GABAB agonist baclofen had no 
effect (Chester and Cunningham, 1999b). Reducing corti-
costerone levels during conditioning via treatment with ami-
noglutethimide also had no effect on the acquisition of EtOH 
CPP (Chester and Cunningham, 1998). Treatment with the 
opioid antagonist naloxone did not alter acquisition of EtOH 
CPP (Cunningham, 1995), but it did enhance the extinction of 
this response (Cunningham et al., 1998). However, μ-recep-
tor knock-out mice show reduced acquisition of EtOH CPP 
(Hall et al., 2001). Finally, inhibition of nitric oxide synthase 
by treatment with 7-nitroindazole prevented the acquisition of 
EtOH CPP (Itzhak and Martin, 2000). 
In summary, a growing collection of studies has been devot-
ed to exploration of the neuropharmacological mechanisms re-
sponsible for EtOH reward measured in the place-conditioning 
paradigm. Several neurotransmitter receptor systems (5-HT1B, 
D1, D2, and μ opioid) are associated with reductions in EtOH 
CPP. Likewise, several neurotransmitter systems (5-HT1A, 5-
HT2, D3, and GABAA) are associated with increases of EtOH 
CPP. In some cases, neuropharmacological manipulations se-
lectively infl uence the acquisition of EtOH CPP when com-
pared with other procedures designed to assess the motivation-
al effects of EtOH. 
SUMMARY 
This symposium provided an overview of several issues in 
the use of place conditioning as a tool for characterizing the 
motivational effects of EtOH. Dr. Rick Bevins presented sev-
eral methodological considerations important for the design 
and interpretation of studies using place conditioning. For ex-
ample, the apparent ease of using this procedure can be off-
set by diffi culties in establishing reliable protocols in the labo-
ratory. Furthermore, characteristics of the procedure related to 
the experience of novelty have the potential to interact with the 
rewarding effects of drugs. Finally, drug reward measured by 
place conditioning may not be subserved by the same process-
es controlling drug self-administration. 
Dr. Frank Holloway discussed the importance of past ex-
perience with EtOH and subsequent changes in EtOH self-ad-
ministration and EtOH reward. For example, tolerance devel-
opment to behavioral disruption caused by EtOH is important 
for the development of EtOH-induced CPP in rats. In contrast, 
EtOH-naive rats show place aversion. Past experience with 
EtOH self-administration also serves to promote the develop-
ment of EtOH CPP in rats. 
Dr. Christopher Cunningham discussed the general fi nding 
that EtOH readily produces CPP in most mouse strains. In this 
species, EtOH CPP is dose-dependent and occurs most robust-
ly with short-duration conditioning trials. Importantly, chang-
ing conditioning parameters such that EtOH exposure occurs 
after conditioning cue exposure results in the production of 
CPA in mice. 
Dr. Fred Risinger reviewed the outcomes of studies designed 
to address the neuropharmacological mechanisms important 
for acquisition of EtOH CPP. Overall, these studies offer sev-
eral instances of neurotransmitter-specifi c actions that increase 
EtOH reward and several examples of neurotransmitter mech-
anisms that reduce EtOH reward. These actions in most cases 
seem specifi c for EtOH reward measured via place condition-
ing compared with other responses, such as conditioned taste 
aversion, EtOH-stimulated activity, and EtOH drinking. 
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